Sanofi, Lilly, Novo and a trio of PBMs face racketeering claims over pricey insulin drugs
13th July 2021 Uncategorised 0 Sanofi, Lilly, Novo and a trio of PBMs face racketeering claims over pricey insulin drugs
fkansteiner
Tue, 07/13/2021 – 11:36
More: Sanofi, Lilly, Novo and a trio of PBMs face racketeering claims over pricey insulin drugs
Source: fierce
